CAAIF-Miravo Healthcare Research Grant in Allergic Rhinitis or Urticaria
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: inquire with unit
Memorial Deadline: Monday 28th, March 2022
External Deadline: Thursday 31st, March 2022
Description
ABOUT CAAIF
The Canadian Asthma, Allergy and Immunology Foundation (CAAIF) is a charitable foundation whose mission is to invest in research leading to new and better treatments that improve the lives of Canadians living with allergy, asthma and immunologic diseases.
ABOUT MIRAVO HEALTHCARE
Miravo is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products. The Company’s products target several therapeutic areas, including pain, allergy, neurology and dermatology. The Company’s strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.
GRANT OBJECTIVE
The objective of the CAAIF-Miravo Healthcare Research Grant in Allergic Rhinitis or Urticaria is to fund a research grant focused on the area of allergic rhinitis or urticaria.
VALUE OF THE AWARD
The maximum value of the award is $25,000.
DURATION
The Research Grant is for one year, non-renewable.
APPLICATION DEADLINE
Applications must be submitted by March 31, 2022 at 11:59 pm in the time zone of the applicant
REQUIREMENTS
ELIGIBILITY
- The award must be held at a Canadian university or research institute defined as an eligible institution by CIHR
- Preference will be given to investigators who have not received this award within the past two years.
For more information click here.